Musk and Altman Head to Court Over OpenAI

Jury selection in the civil trial filed by Elon Musk against Sam Altman and other OpenAI-related defendants is scheduled to begin on Monday in a federal courthouse in Oakland, California, with the trial expected to last several weeks, reporting by NBC News and Reuters shows. U.S. District Judge Yvonne Gonzalez Rogers issued a ruling on April 24 that dismissed Musk's fraud and constructive fraud claims at Musk's request while permitting breach-of-charitable-trust and unjust-enrichment claims to proceed, Reuters reported.

The lawsuit, originally filed in 2024, alleges that OpenAI's shift from a nonprofit structure toward a for-profit model violated founding commitments; The Guardian and Reuters summarise that Musk contends Altman and others betrayed OpenAI's original mission. Musk has sought very large damages, with Reuters reporting a $150 billion figure according to a person involved in the case and The Guardian citing a $134 billion estimate. Court filings unsealed and reported by The Washington Post and other outlets include private emails, texts and diary entries from Musk, Altman and other Silicon Valley participants.

Reporting across NBC, The Guardian and Reuters lists likely witnesses that may include Musk, Altman, OpenAI board members and senior executives; Microsoft is repeatedly identified in press coverage as a major investor in OpenAI. Reuters has also reported that OpenAI is preparing for a potential IPO that some coverage places at a valuation as high as $1 trillion.

Litigation that centers on corporate form and governance at a high-profile AI company puts public attention on how capital structures interact with long-term research goals. Companies that combine nonprofit mission statements with investor-backed commercial entities commonly face legal and governance scrutiny, and practitioners should note that such arrangements can surface contract, fiduciary and disclosure disputes under adversarial review.

For the AI ecosystem, this trial is significant because it foregrounds questions of governance, transparency and incentive alignment at a leading model developer. Public coverage, including detailed court filings and media reporting in The New York Times, The Washington Post and The Guardian, may influence how investors, potential hires and regulators evaluate trade-offs between mission-driven research and commercial scaling. High-profile testimony and unsealed communications also risk shaping narratives about leadership, ethics and trust in the sector regardless of the legal outcome.

Observers should track four indicators during the trial:

• •the extent to which unsealed communications clarify decision points around OpenAI's 2019 reorganisation
• •testimony from major investors such as Microsoft about their contractual relationships and expectations
• •any judicial findings on remedies that might affect corporate governance or distributions between for-profit and nonprofit vehicles
• •market and personnel reactions, including investor statements or hiring freezes, reported in the business press. None of these items prescribes action to the parties; they are observable signals that will matter to practitioners monitoring governance risk and investor sentiment

Legal disputes over corporate form and mission create downstream operational risks, from potential shifts in funding and partnerships to public scrutiny of model release practices. Teams building or collaborating with high-profile AI firms should expect increased emphasis on documented governance, clear funding and IP arrangements, and proactive communications with partners when corporate structures blur nonprofit and commercial roles.

What happened paragraphs draw directly on reporting by Reuters, NBC News, The Guardian, The Washington Post and other outlets covering the trial and unsealed filings. Where high-stakes figures or rulings are cited, they are attributed to the specific outlets that reported them.